(-0.46%) 5 048.42 points
(-0.98%) 38 086 points
(-0.64%) 15 612 points
(0.25%) $83.78
(-3.48%) $1.581
(0.04%) $2 343.50
(0.24%) $27.42
(0.63%) $926.30
(0.03%) $0.932
(0.02%) $10.95
(0.01%) $0.799
(0.00%) $92.17
Live Chart Being Loaded With Signals
Jacobson Pharma Corporation Limited, through its subsidiaries, produces, markets, and sells generic drugs and branded healthcare products in Hong Kong, Mainland China, Macau, Singapore, and internationally...
Stats | |
---|---|
Today's Volume | 148 000 |
Average Volume | 538 306 |
Market Cap | 1.13B |
EPS | HKD0.0272 ( 2023-06-15 ) |
Last Dividend | HKD0.0238 ( 2023-08-15 ) |
Next Dividend | HKD0 ( N/A ) |
P/E | 5.18 |
ATR14 | HKD0 (0.00%) |
Jacobson Pharma Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Jacobson Pharma Financials
Annual | 2022 |
Revenue: | HKD1.79B |
Gross Profit: | HKD747.17M (41.84 %) |
EPS: | HKD0.130 |
Q2 | 2023 |
Revenue: | HKD714.92M |
Gross Profit: | HKD301.08M (42.11 %) |
EPS: | HKD0.0658 |
Q4 | 2022 |
Revenue: | HKD968.23M |
Gross Profit: | HKD406.74M (42.01 %) |
EPS: | HKD0.0604 |
Q3 | 2022 |
Revenue: | HKD484.11M |
Gross Profit: | HKD203.37M (42.01 %) |
EPS: | HKD0.0272 |
Financial Reports:
No articles found.
Jacobson Pharma Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
HKD0 (N/A) |
HKD0.0548 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0.0238 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | HKD0.00800 | 2017-01-09 |
Last Dividend | HKD0.0238 | 2023-08-15 |
Next Dividend | HKD0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 14 | -- |
Total Paid Out | HKD0.264 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 3.52 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 4.45 | |
Div. Directional Score | 7.93 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
8095.HK | Ex Dividend Junior | 2023-10-17 | Sporadic | 0 | 0.00% | |
2018.HK | Ex Dividend Knight | 2023-05-29 | Annually | 0 | 0.00% | |
1093.HK | Ex Dividend Knight | 2023-09-07 | Annually | 0 | 0.00% | |
0168.HK | Ex Dividend Knight | 2023-06-21 | Annually | 0 | 0.00% | |
3709.HK | Ex Dividend Knight | 2023-06-14 | Annually | 0 | 0.00% | |
1666.HK | Ex Dividend Knight | 2023-06-19 | Annually | 0 | 0.00% | |
0709.HK | Ex Dividend Knight | 2023-09-05 | Semi-Annually | 0 | 0.00% | |
2219.HK | Ex Dividend Knight | 2023-06-12 | Annually | 0 | 0.00% | |
1234.HK | Ex Dividend Knight | 2023-09-05 | Semi-Annually | 0 | 0.00% | |
0305.HK | Ex Dividend Junior | 2023-06-15 | Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.143 | 1.500 | 7.14 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0604 | 1.200 | 7.99 | 9.59 | [0 - 0.3] |
returnOnEquityTTM | 0.0959 | 1.500 | -0.0452 | -0.0679 | [0.1 - 1] |
payoutRatioTTM | 0.621 | -1.000 | 3.79 | -3.79 | [0 - 1] |
currentRatioTTM | 1.283 | 0.800 | 8.58 | 6.87 | [1 - 3] |
quickRatioTTM | 1.009 | 0.800 | 8.77 | 7.01 | [0.8 - 2.5] |
cashRatioTTM | 0.788 | 1.500 | 6.73 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.329 | -1.500 | 4.52 | -6.79 | [0 - 0.6] |
interestCoverageTTM | 3.30 | 1.000 | 9.89 | 9.89 | [3 - 30] |
operatingCashFlowPerShareTTM | 0.330 | 2.00 | 9.89 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.271 | 2.00 | 9.86 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.574 | -1.500 | 7.70 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.421 | 1.000 | 6.32 | 6.32 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.182 | 1.000 | 8.37 | 8.37 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.482 | 1.000 | 8.43 | 8.43 | [0.2 - 2] |
assetTurnoverTTM | 0.422 | 0.800 | -0.519 | -0.415 | [0.5 - 2] |
Total Score | 11.41 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 4.45 | 1.000 | 9.65 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0959 | 2.50 | -0.0291 | -0.0679 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.271 | 2.00 | 9.91 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 8.71 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 0.330 | 2.00 | 9.89 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.621 | 1.500 | 3.79 | -3.79 | [0 - 1] |
pegRatioTTM | 0.111 | 1.500 | -2.60 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.375 | 1.000 | 3.12 | 0 | [0.1 - 0.5] |
Total Score | 4.45 |
Jacobson Pharma
Jacobson Pharma Corporation Limited, through its subsidiaries, produces, markets, and sells generic drugs and branded healthcare products in Hong Kong, Mainland China, Macau, Singapore, and internationally. The company offers generic drugs for various therapeutic categories, including the respiratory, cardiovascular, central nervous system, gastrointestinal, genito-urinary, musculoskeletal, endocrine and metabolic, dermatological, anti-allergics, scar treatment, oral anti-diabetics, and anti-infective, as well as arsenic trioxide oral solutions, rosuvastatin tablets, and atorvastatin tablets. It also provides branded medicines; health and wellness products; and proprietary Chinese medicines, such as Po Chai pills, Ho Chai Kung Tji Thung San, Tong Tai Chung Woodlok oil, Flying Eagle Woodlok Oil, Saplingtan, Shiling oil, Contractubex, Doan's Ointment, and Col-gan tablets. In addition, it engages in the trading of medical supplies; procurement of packaging materials; sale of healthcare and herbal products; research and development; and property holding activities. Jacobson Pharma Corporation Limited sells its products to hospitals and clinics, and registered pharmacies, as well as to doctors in private and retail outlets, and trading companies. The company was incorporated in 2016 and is headquartered in Kwun Tong, Hong Kong. Jacobson Pharma Corporation Limited is a subsidiary of Kingshill Development Limited.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators